Home Lepu Medical Announces NMPA Approval of Drug-Coated Coronary Balloon Catheter and Left Atrial Appendage Occluder System

Lepu Medical Announces NMPA Approval of Drug-Coated Coronary Balloon Catheter and Left Atrial Appendage Occluder System

Jun 12, 2020 20:31 CST Updated 20:31
Shape Memory Alloy

Structural Heart Disease Medical Product R&D and Manufacturer

Lepu Medical

Developer and Manufacturer of Cardiac Interventional Medical Devices and Pharmaceuticals

Original Title:Lepu Medical: Drug-Coated Coronary Balloon Catheters and Left Atrial Appendage Occluder Systems Approved by the National Medical Products Administration Source: Cailianshe

[Lepu Medical: Drug-Coated Coronary Balloon Catheter and Left Atrial Appendage Occluder System Approved by the National Medical Products Administration] Cailian Press, June 12 – Lepu Medical announced that its independently developed “Drug-Coated Coronary Balloon Catheter” (Vesselin) and the Left Atrial Appendage Occluder System (MemoLefort), independently developed by its wholly-owned subsidiary Shanghai Shape Memory Alloy Co., Ltd., have received registration approval from the National Medical Products Administration of China, obtaining the “Medical Device Registration Certificate.”